Login to Your Account

FDA maps out the route to market for interchangeables

By Mari Serebrov
Regulatory Editor

Tuesday, January 17, 2017

At last, the FDA has delivered on its promise to issue guidance on interchangeability, opening the door to automatic pharmacy substitution and the closest thing possible to a generic biologic.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription